Steven M. Rauscher
Founder at Biopharm Physicians LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Funck | M | 62 | 37 years | |
John Kelley | M | 70 | 16 years | |
Jeffrey Peterson | M | 68 |
Target Discovery, Inc.
Target Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Target Discovery, Inc. provides scientific research services. It discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and the management of diseases. The firm’s products address prostate cancer aggressiveness, and chemotherapy selection in breast and ovarian cancer. The company was founded by Luke V. Schneider in 1999 and is headquartered in Palo Alto, CA. | 25 years |
Kerry Clem | M | 54 | 13 years | |
Scott House | M | - | 34 years | |
Peder Jensen | M | 69 | 13 years | |
Luke V. Schneider | M | - |
Target Discovery, Inc.
Target Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Target Discovery, Inc. provides scientific research services. It discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and the management of diseases. The firm’s products address prostate cancer aggressiveness, and chemotherapy selection in breast and ovarian cancer. The company was founded by Luke V. Schneider in 1999 and is headquartered in Palo Alto, CA. | 25 years |
Clayton Struve | M | - |
Target Discovery, Inc.
Target Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Target Discovery, Inc. provides scientific research services. It discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and the management of diseases. The firm’s products address prostate cancer aggressiveness, and chemotherapy selection in breast and ovarian cancer. The company was founded by Luke V. Schneider in 1999 and is headquartered in Palo Alto, CA. | 24 years |
David C. Bomberger | M | - |
Target Discovery, Inc.
Target Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Target Discovery, Inc. provides scientific research services. It discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and the management of diseases. The firm’s products address prostate cancer aggressiveness, and chemotherapy selection in breast and ovarian cancer. The company was founded by Luke V. Schneider in 1999 and is headquartered in Palo Alto, CA. | - |
Nikolaos T. Liakounakos | M | - | 12 years | |
Leon Yengoyan | M | - |
Target Discovery, Inc.
Target Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Target Discovery, Inc. provides scientific research services. It discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and the management of diseases. The firm’s products address prostate cancer aggressiveness, and chemotherapy selection in breast and ovarian cancer. The company was founded by Luke V. Schneider in 1999 and is headquartered in Palo Alto, CA. | - |
Connections Chart
Multi-company connection
Former connections
Statistics
Country | Connections | % of total |
---|---|---|
United States | 98 | 98.00% |
Greece | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Steven M. Rauscher
- Personal Network